Evolution of Tumor Necrosis Factor-α serum concentrations in HIV infected individuals treated with zidovudine

Pathologie Biologie

Volumn 44, Issue 8, 1996, Pages 716-719

  Morlat, P ^a   Chene, G ^a   Ragnaud, J M ^a   Mercie, P ^a   Grobost, F ^a   Bernard, N ^a   Lacoste, D ^a   Beylot, J ^a   Aubertin, J ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

prognostic marker; Tumor Necrosis Factor; zidovudine

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; RADIOIMMUNOASSAY;

ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

EID: 0029843354     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)